The U.S. NIH is experiencing a major shift in its research focus, as directed by the White House, to investigate regret associated with gender transition. The new directive comes after the federal agency has seen its funding for transgender health research significantly reduced by over $180 million. Many NIH employees have described the directive as unprecedented, inflammatory, and ideologically biased, suggesting that it reduces the complex identity of transgender people to solely their transition experiences and feelings of regret. Critics, including health experts, view this move as a harmful stigmatization of transgender individuals.
It's really pigeonholing trans people into this medical lens where the only thing important to know about them is that they seek medical transition and regret it.
This directive's specificity, inflammatory language and focus on a hyper-polarizing topic are unprecedented, according to NIH employees.
Collection
[
|
...
]